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INTRODUCTION:  Juvenile  nasopharyngeal  angioﬁbroma  (JNA)  is a  benign  though  locally  aggressive,  highly
vascular  tumor  primarily  affecting  adolescent  males  which  has  traditionally  posed  a signiﬁcant  intraop-
erative  challenge  during its  resection  due  to the  high  risk  of  uncontrollable  hemorrhage.  Pre-operative
angiographic  embolization  of  the major  feeding  vessels  to the  tumor  has become  a valuable,  even nec-
essary,  tool  in the surgical  treatment  of  these  lesions.
PRESENTATION  OF  CASE:  Our  patient  was  a 32-year-old  man  with  a chief  complaint  of  recurrent  left-sided
epistaxis  for  one  year,  brisk  and  continuous  for ten  days  prior  to presentation,  subsequently  found  to  have
a 4 cm  vascular  skull  base  tumor  causing  mild  expansion  of the pterygopalatine  fossa.  The  patient  under-
went pre-operative  embolization  utilizing  300–500  micrometer  microspheres  injected  into  the  ipsilateral
maxillary  artery.  The  following  day,  the  patient  underwent  deﬁnite  Stereotactical  surgical  resection  of
his JNA  tumor.  Estimated  blood  loss during  the  operation  was  50 mL, and  the  patient  was  discharged  the
same  day.
DISCUSSION:  Juvenile  nasopharyngeal  angioﬁbromas  pose  a signiﬁcant  bleeding  risk  for  the  surgeon  due
to their  highly  vascular  nature.  Pre-operative  embolization  of  juvenile  nasopharyngeal  angioﬁbromas  can
reduce intraoperative  blood  loss  while  lessening  the  risk  of  massive  hemorrhage,  shortening  operation
times,  increasing  intra-operative  visibility,  and  allowing  for easier  resection  of  lesions.
CONCLUSION:  Pre-operative  embolization  of  JNA  is  a safe,  effective  method  to prevent  against  the risk  of
massive,  sometimes  fatal,  hemorrhage  that  occurs  with  these  highly  vascular  tumors.
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. Introduction
Juvenile nasopharyngeal angioﬁbroma is a relatively uncom-
on, benign tumor of children which accounts for approximately
.05% of all head and neck tumors.1 The lesion almost exclusively
ffects males, usually around the age of adolescence with a range
nvolving boys from ages 7 to 29.1 Initial symptoms upon presenta-
ion include recurrent unilateral epistaxis, nasal obstruction, nasal
rainage and a nasopharyngeal mass. Although a benign tumor,
esions may  be locally aggressive and erode into the surrounding
sseous and soft tissue structures, arising from their usual loca-
ion in the lateral nasopharynx near the superior border of the
phenopalatine foramen. Histopathologically, the tumor is com-
rised of haphazardly arranged vascular channels surrounded by
ense paucicellular ﬁbroblastic stroma, with the myoﬁbroblast
eing the principal cell.2,3 The bleeding propensity of these tumors
s due to the ﬁndings that the smaller vessels in the center of
he lesion tend to lack muscular elastic lamina, predisposing these
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vessels without a muscular surrounding layer that may  otherwise
assist in vasoconstriction to uncontrolled bleeding.2 The blood sup-
ply to these lesions is derived from the internal maxillary artery,8,9
a branch off the external carotid artery.
Diagnosis of JNA may  originally be made on computed tomo-
graphy (CT) examination or even suspected on the basis of plain
radiographs. CT has the beneﬁt of better detailing osseous involve-
ment of tumor. Deﬁnitive diagnosis, however, is made on magnetic
resonance imaging (MRI) examination. The optimal sequence to
identify the anatomy and extent of intracranial extension of JNA
involves T1 weighted imaging (T1WI) with gadolinium contrast,
utilizing fat-suppression. An MR-angiogram can additionally be
valuable in deﬁning the arterial supply to the tumor, of primary
importance for pre-embolization planning. Due to the highly vascu-
lar nature of JNA, biopsy is contraindicated.10 Furthermore, careful
attention must be paid to the surrounding vascular structures
during time of resection accounting for the high risk of poten-
tially fatal bleeding. Speciﬁcally, feeding vessels from the internal
carotid artery, as well as any arterial supply from the contralat-
eral external carotid artery must be identiﬁed prior to attempted
resection. Although surgical resection remains deﬁnite treatment
for these lesions, pre-operative angioembolization is increasingly
recommended to minimize the risk of uncontrolled intraoperative
ssociates Ltd. This is an open access article under the CC BY-NC-ND license
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sig. 1. (a) Axial unenhanced CT image of the face demonstrates a soft tissue mass in
 soft tissue mass within the left maxillary sinus and osteomeatal units.
emorrhage. Previously described treatments including radiation,
ryotherapy, electrocoagulation, or hormonal therapy have proven
ess effective with increased recurrence rate and a greater incidence
f side effects.3,4
. Case report
Our patient was a 32-year-old man  with a chief complaint
f recurrent left-sided epistaxis for one year, brisk and continu-
us for ten days prior to presentation. The Otolaryngology (ENT)
ervice was consulted due to uncontrollable epistaxis, and imaging
ork-up with computed tomography (Fig. 1) followed by con-rast enhanced MRI  (Fig. 2) revealed a 3–4 cm vascular skull base
umor with mild proximal expansion of the pterygopalatine fossa
nd extension into the nasopharynx and left pterygoid plate, most
onsistent with a Radkowski IIA lesion.11 Plans were made for
ig. 2. (a) Axial contrast enhanced MR  T1 weighted image demonstrates an enhancing s
inus,  crossing midline. (b) Coronal contrast enhanced MR T1 weighted image demonstraft sphenoid sinus. (b) Coronal CT image of the face demonstrates opaciﬁcation with
surgical resection, and the Interventional Radiology service was
subsequently consulted by ENT for pre-operative embolization to
take place on the day prior to surgical resection.
In the Interventional Suite, the right femoral artery was
accessed, and a 5-French Berenstein (Cordis Endovascular, John-
son and Johnson Corp., Miami, FL) was  eventually placed to
access the common carotid artery. An angiogram of the right
common carotid and selective angiogram of the right external
carotid artery revealed normal arterial anatomy with no sig-
niﬁcant tumor blush. Subsequently, an angiogram of the left
common carotid artery was performed revealing normal branch-
ing of the internal and external carotid arteries with signiﬁcant
tumor blush in the skull base (Fig. 3). A normal left sphenopala-
tine artery could not be identiﬁed, as numerous abnormal vessels
had replaced the sphenopalatine artery due to neovasculariza-
tion (Fig. 4). Selective injections evaluating the occipital and facial
oft tissue mass arising from the skull base and left nasopharynx into the sphenoid
tes an enhancing soft tissue mass within the maxillary sinus and osteomeatal units.
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Fig. 3. Angiogram demonstrating neovascularization and characteristic tumor
blush in the left nasopharynx. No contribution from the right-sided arterial supply.
Fig. 4. Replacement of the normal left sphenopalatine artery with tumor neovas-
cularization. No vessels are seen supplying the tumor at the base of the skull.Fig. 5. Post-embolization angiogram demonstrating cessation of ﬂow within the
tumor blush following Embosphere administration and embolization of the proxi-
mal  sphenopalatine artery with a microcoil.
arteries demonstrated no vessels supplying the tumor at the base
of the skull.
The Berenstein catheter was  subsequently advanced into the
internal maxillary artery, and after diagnostic angiogram revealed
no intracranial branches nor branches to the globe, it was deemed
safe to proceed with embolization. 300–500 micrometer Embo-
sphere (Merit Medical Systems, South Jordan, UT) microspheres
were dispensed in small aliquots until there was stasis within
the tumor bed, and a follow-up arteriogram demonstrated cessa-
tion of ﬂow with no further tumor blush visualized. Finally, the
microcatheter was retracted into the proximal left sphenopalatine
artery and a single 3 mm × 6 cm microcoil was placed. A follow-
up angiogram demonstrated cessation of ﬂow within the vessel
(Fig. 5). Additionally, no new vessels were identiﬁed supplying the
tumor at the base of the skull. After removal of the catheters and
closure of the arteriotomy, the patient was  returned to the holding
area; no immediate complications were identiﬁed.
The following day the patient returned to the operating room
with Otolaryngology for deﬁnitive resection. Stereotactical surgi-
cal navigation and resection was  performed, and estimated blood
loss during the operation was  50 mL.  The patient’s operation and
post-operative course were uncomplicated, and the patient was
discharged home in stable condition the same day following his
operation.
3. Discussion
In the past several years, the value of pre-operative emboliza-
tion prior to surgery has become increasingly known. The risk for
intra-operative bleeding is signiﬁcant, and furthermore as diag-
nosis is often delayed, these tumors may  lie adjacent to several
critical neurovascular structures.5,6 Pre-operative embolization of
juvenile nasopharyngeal angioﬁbromas can reduce intraoperative
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lood loss while lessening the risk of massive hemorrhage, short-
ning operation times, increasing intra-operative visibility, and
llowing for easier resection of lesions. Furthermore, the diagnostic
ngiogram itself may  be a valuable predictor of expected intraop-
rative blood loss.7 Although serious complications are sometimes
ossible, including stroke or blindness from migration of particles
nto the middle cerebral artery or ophthalmic artery, these compli-
ations are rare and do not outweigh the substantial beneﬁts that
mbolization confers.9 In a study of eight patients that underwent
re-operative embolization of the ipsilateral maxillary artery utiliz-
ng absorbable gelfoam, six experienced considerably less bleeding
uring surgical resection.2 A recent systematic analysis of 131 cases
ithin 57 studies over 21 years showed that the average blood
oss in patients that underwent pre-operative embolization during
urely endoscopic surgical resection averaged 406.7 mL  compared
o 828.3 mL  in non-embolized patient undergoing purely endo-
copic resection.1 Furthermore, in open surgical cases there was
ess blood loss after preoperative embolization with an average of
85.0 mL  compared to an average of 1912.1 mL  lost in patients that
id not undergo embolization. In light of these ﬁndings, it appears
hat pre-operative embolization is a safe, effective method to pre-
ent against the risk of massive, sometimes fatal, hemorrhage that
ccurs with these highly vascular tumors. Our case is unique as our
patient presented at the age of 32, while most patients requiring
embolization present in late adolescence with a mean age of 17.1
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Key learning points
• Juvenile nasopharyngeal angioﬁbromas (JNA) are a benign tumor that pose signiﬁcant challenges upon surgical
resection due to risk of excessive bleeding.
• Pre-operative embolization of JNA utilizing microspheres is a valuable pre-operative technique performed by the
Interventional Radiologist to diminish risk of intraoperative bleeding.
• Although uncommon, delayed presentation of JNA may  occur in an adult and account for lateonset recurrent unilateral
epistaxis.
• The ipsilateral internal maxillary artery in the majority of cases comprises the primary vascular supply to JNA.
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